-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Lung cancer screening (LCS) by low-dose computed tomography ( LDCT) can diagnose lung cancer (LC) early , thereby significantly reducing LC mortality.
Lung cancer screening (LCS) by low-dose computed tomography ( LDCT) can diagnose lung cancer (LC) early , thereby significantly reducing LC mortality.
The effect of annual screening depends on the individual risk assessment of LC.
Recently, a study published in European Radiology reported the distribution of Lung-RADS v1.
Subjects were selected retrospectively in the Multicenter Italian Lung Testing (MILD) trial based on the National Lung Screening Test ( NLST) standards.
Subjects were selected retrospectively in the Multicenter Italian Lung Testing (MILD) trial based on the National Lung Screening Test ( NLST) standards.
Among 1248 subjects who met NLST, the frequency of LC occurrence was 1.
Based on the results of LDCT at baseline, the kaplan-meier curve for the diagnosis of LC within 3 years.
Based on the results of LDCT at baseline, the kaplan-meier curve for the diagnosis of LC within 3 years.
Table According to the results of LDCT at baseline, the stage and histological distribution of LC within a 3-year interval
Table According to the results of LDCT at baseline, the stage and histological distribution of LC within a 3-year intervalIn summary, this study is the first to use semi-automatic software to segment the nodule volume on thin-layer LDCT to analyze the distribution of Lung-RADS v1.
In summary, this study is the first to use semi-automatic software to segment the nodule volume on thin-layer LDCT to analyze the distribution of Lung-RADS v1.
The nodule volume obtained by semi-automatic software segmentation can stratify the LC risk of Lung-RADS v1.
Original source: Original source:
Mario Silva,Gianluca Milanese,Stefano Sestini,et al.
Mario Silva,Gianluca Milanese,Stefano Sestini,et al.
Lung cancer screening by nodule volume in Lung-RADS v1.
1: negative baseline CT yields potential for increased screening interval.
DOI: org/10.
1007/s00330-020-07275-w">10.
1007/s00330-020-07275-w Mario Silva, Gianluca Milanese,Stefano Sestini,et al.
Lung cancer screening by nodule volume in Lung-RADS v1.
1: negative baseline CT yields potential for increased screening interval.
DOI: org/10.
1007/s00330-020-07275-w">10.
1007/s00330-020-07275-worg/10.
1007/s00330-020-07275-w"> 10.
1007/s00330-020- 07275-w Leave a message here
